Cargando…
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Patients with cancer are at higher risk of severe coronavirus infectious disease 2019 (COVID-19), but the mechanisms underlying virus–host interactions during cancer therapies remain elusive. When comparing nasopharyngeal swabs from cancer and noncancer patients for RT-qPCR cycle thresholds measurin...
Ejemplares similares
-
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
por: Danlos, François-Xavier, et al.
Publicado: (2021) -
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
por: Fahrner, Jean-Eudes, et al.
Publicado: (2022) -
Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors
por: Daillère, Romain, et al.
Publicado: (2020) -
Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients
por: Bourgin, Mélanie, et al.
Publicado: (2021) -
Immune responses during COVID-19 infection
por: Melenotte, Cléa, et al.
Publicado: (2020)